Changes in tissue inflammation, angiogenesis and apoptosis in endometriosis, adenomyosis and uterine myoma after GnRH agonist therapy

By Khan Khaleque Newaz   Kitajima Michio   Hiraki Koichi   Fujishita Akira   Sekine Ichiro   Ishimaru Tadayuki   Masuzaki Hideaki  

Human Reproduction, Vol. 25, Iss. 3, 2010-03 ,pp. : 642-653

Oxford University Press

Access to resources Recommend Favorite

Long‐term effectiveness and safety of GnRH agonist plus raloxifene administration in women with uterine leiomyomas

By Palomba Stefano  

Human Reproduction, Vol. 19, Iss. 6, 2004-06 ,pp. : 1308-1314

Oxford University Press

Access to resources Recommend Favorite

Ovarian stimulation in women with high and normal body mass index: GnRH agonist versus GnRH antagonist

By Marci Roberto   Lisi Franco   Soave Ilaria   Lo Monte Giuseppe   Patella Alfredo   Caserta Donatella   Moscarini Massimo  

Gynecological Endocrinology, Vol. 28, Iss. 10, 2012-10 ,pp. : 792-795

Informa Healthcare

Access to resources Recommend Favorite

Reproductive pathology. GnRH agonist-suppressed expression of nitric oxide synthases and generation of peroxynitrite in adenomyosis

By Kamada Yasuhiko   Nakatsuka Mikiya   Asagiri Kazuo   Noguchi Soichi   Habara Toshihiro   Takata Masayo  

Human Reproduction, Vol. 15, Iss. 12, 2000-12 ,pp. : 2512-2519

Oxford University Press

Access to resources Recommend Favorite

Effect of GnRH analogues on apoptosis and release of interleukin‐1 and vascular endothelial growth factor in endometrial cell cultures from patients with endometriosis

By Meresman Gabriela F.  

Human Reproduction, Vol. 18, Iss. 9, 2003-09 ,pp. : 1767-1771

Oxford University Press

Access to resources Recommend Favorite